Cargando…

Cost-effectiveness of gargling for the prevention of upper respiratory tract infections

BACKGROUND: In Japan, gargling is a generally accepted way of preventing upper respiratory tract infection (URTI). The effectiveness of gargling for preventing URTI has been shown in a randomized controlled trial that compared incidences of URTI between gargling and control groups. From the perspect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Michi, Shimbo, Takuro, Omata, Kazumi, Takahashi, Yoshimitsu, Satomura, Kazunari, Kitamura, Tetsuhisa, Kawamura, Takashi, Baba, Hisamitsu, Yoshihara, Masaharu, Itoh, Hiroshi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651874/
https://www.ncbi.nlm.nih.gov/pubmed/19087312
http://dx.doi.org/10.1186/1472-6963-8-258
_version_ 1782165201560272896
author Sakai, Michi
Shimbo, Takuro
Omata, Kazumi
Takahashi, Yoshimitsu
Satomura, Kazunari
Kitamura, Tetsuhisa
Kawamura, Takashi
Baba, Hisamitsu
Yoshihara, Masaharu
Itoh, Hiroshi
author_facet Sakai, Michi
Shimbo, Takuro
Omata, Kazumi
Takahashi, Yoshimitsu
Satomura, Kazunari
Kitamura, Tetsuhisa
Kawamura, Takashi
Baba, Hisamitsu
Yoshihara, Masaharu
Itoh, Hiroshi
author_sort Sakai, Michi
collection PubMed
description BACKGROUND: In Japan, gargling is a generally accepted way of preventing upper respiratory tract infection (URTI). The effectiveness of gargling for preventing URTI has been shown in a randomized controlled trial that compared incidences of URTI between gargling and control groups. From the perspective of the third-party payer, gargling is dominant due to the fact that the costs of gargling are borne by the participant. However, the cost-effectiveness of gargling from a societal perspective should be considered. In this study, economic evaluation alongside a randomized controlled trial was performed to evaluate the cost-effectiveness of gargling for preventing URTI from a societal perspective. METHODS: Among participants in the gargling trial, 122 water-gargling and 130 control subjects were involved in the economic analysis. Sixty-day cumulative follow-up costs and effectiveness measured by quality-adjusted life days (QALD) were compared between groups on an intention-to-treat basis. Incremental cost-effectiveness ratio (ICER) was converted to dollars per quality-adjusted life years (QALY). The 95% confidence interval (95%CI) and probability of gargling being cost-effective were estimated by bootstrapping. RESULTS: After 60 days, QALD was increased by 0.43 and costs were $37.1 higher in the gargling group than in the control group. ICER of the gargling group was $31,800/QALY (95%CI, $1,900–$248,100). Although this resembles many acceptable forms of medical intervention, including URTI preventive measures such as influenza vaccination, the broad confidence interval indicates uncertainty surrounding our results. In addition, one-way sensitivity analysis also indicated that careful evaluation is required for the cost of gargling and the utility of moderate URTI. The major limitation of this study was that this trial was conducted in winter, at a time when URTI is prevalent. Care must be taken when applying the results to a season when URTI is not prevalent, since the ICER will increase due to decreases in incidence. CONCLUSION: This study suggests gargling as a cost-effective preventive strategy for URTI that is acceptable from perspectives of both the third-party payer and society.
format Text
id pubmed-2651874
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26518742009-03-06 Cost-effectiveness of gargling for the prevention of upper respiratory tract infections Sakai, Michi Shimbo, Takuro Omata, Kazumi Takahashi, Yoshimitsu Satomura, Kazunari Kitamura, Tetsuhisa Kawamura, Takashi Baba, Hisamitsu Yoshihara, Masaharu Itoh, Hiroshi BMC Health Serv Res Research Article BACKGROUND: In Japan, gargling is a generally accepted way of preventing upper respiratory tract infection (URTI). The effectiveness of gargling for preventing URTI has been shown in a randomized controlled trial that compared incidences of URTI between gargling and control groups. From the perspective of the third-party payer, gargling is dominant due to the fact that the costs of gargling are borne by the participant. However, the cost-effectiveness of gargling from a societal perspective should be considered. In this study, economic evaluation alongside a randomized controlled trial was performed to evaluate the cost-effectiveness of gargling for preventing URTI from a societal perspective. METHODS: Among participants in the gargling trial, 122 water-gargling and 130 control subjects were involved in the economic analysis. Sixty-day cumulative follow-up costs and effectiveness measured by quality-adjusted life days (QALD) were compared between groups on an intention-to-treat basis. Incremental cost-effectiveness ratio (ICER) was converted to dollars per quality-adjusted life years (QALY). The 95% confidence interval (95%CI) and probability of gargling being cost-effective were estimated by bootstrapping. RESULTS: After 60 days, QALD was increased by 0.43 and costs were $37.1 higher in the gargling group than in the control group. ICER of the gargling group was $31,800/QALY (95%CI, $1,900–$248,100). Although this resembles many acceptable forms of medical intervention, including URTI preventive measures such as influenza vaccination, the broad confidence interval indicates uncertainty surrounding our results. In addition, one-way sensitivity analysis also indicated that careful evaluation is required for the cost of gargling and the utility of moderate URTI. The major limitation of this study was that this trial was conducted in winter, at a time when URTI is prevalent. Care must be taken when applying the results to a season when URTI is not prevalent, since the ICER will increase due to decreases in incidence. CONCLUSION: This study suggests gargling as a cost-effective preventive strategy for URTI that is acceptable from perspectives of both the third-party payer and society. BioMed Central 2008-12-16 /pmc/articles/PMC2651874/ /pubmed/19087312 http://dx.doi.org/10.1186/1472-6963-8-258 Text en Copyright © 2008 Sakai et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sakai, Michi
Shimbo, Takuro
Omata, Kazumi
Takahashi, Yoshimitsu
Satomura, Kazunari
Kitamura, Tetsuhisa
Kawamura, Takashi
Baba, Hisamitsu
Yoshihara, Masaharu
Itoh, Hiroshi
Cost-effectiveness of gargling for the prevention of upper respiratory tract infections
title Cost-effectiveness of gargling for the prevention of upper respiratory tract infections
title_full Cost-effectiveness of gargling for the prevention of upper respiratory tract infections
title_fullStr Cost-effectiveness of gargling for the prevention of upper respiratory tract infections
title_full_unstemmed Cost-effectiveness of gargling for the prevention of upper respiratory tract infections
title_short Cost-effectiveness of gargling for the prevention of upper respiratory tract infections
title_sort cost-effectiveness of gargling for the prevention of upper respiratory tract infections
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651874/
https://www.ncbi.nlm.nih.gov/pubmed/19087312
http://dx.doi.org/10.1186/1472-6963-8-258
work_keys_str_mv AT sakaimichi costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections
AT shimbotakuro costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections
AT omatakazumi costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections
AT takahashiyoshimitsu costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections
AT satomurakazunari costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections
AT kitamuratetsuhisa costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections
AT kawamuratakashi costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections
AT babahisamitsu costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections
AT yoshiharamasaharu costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections
AT itohhiroshi costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections
AT costeffectivenessofgarglingforthepreventionofupperrespiratorytractinfections